Changes of Early Sepsis Biomarker Presepsin Level during Hemodialysis: Influence of β(2)-Microglobulin Clearance of Dialysis Membrane: A Preliminary Study

血液透析过程中早期脓毒症生物标志物前降钙素原水平的变化:透析膜β2-微球蛋白清除的影响:一项初步研究

阅读:1

Abstract

BACKGROUND: Although presepsin (P-SEP) is an early sepsis biomarker, sepsis is often suspected after starting hemodialysis (HD). To enhance the utility of P-SEP, we investigated whether pre-HD P-SEP levels could be predicted using the P-SEP levels from blood samples collected after starting HD. METHODS: We observed P-SEP level changes due to HD and dialyzer passage in HD patients using a dialysis membrane with a β(2)-microglobulin (β(2)-MG) clearance of either ≥50 mL/min (high-flux) or < 30 mL/min (intermediate-flux). We calculated the removal ratios for the elimination of P-SEP or the predicted pre-HD P-SEP levels based on the correction of hemoconcentration. RESULTS: The P-SEP levels significantly decreased at 4 h after starting HD (n = 8) using membranes with a β(2)-MG clearance ≥50 mL/min; the removal ratios at 2 and 4 h were 42.8 ± 7.9% and 58.8 ± 18.4%, respectively. In contrast, the P-SEP levels did not decrease during the passage of dialyzer in 2 patients with a β(2)-MG clearance < 30 mL/min, and the P-SEP levels increased during HD in all patients (n = 10, including the abovementioned 2 patients) with a β(2)-MG clearance < 30 mL/min. The predicted pre-HD P-SEP levels (y) were strongly correlated with the actually measured pre-HD P-SEP levels (x) (R (2) = 0.9562) using the regression equation: y = 1.0987x. CONCLUSION: The levels of P-SEP with a molecular weight near that of β(2)-MG decreased similarly to those of β(2)-MG during HD using membranes with a β(2)-MG clearance ≥50 mL/min. On the contrary, the levels of P-SEP rather increased during HD with a β(2)-MG clearance < 30 mL/min, suggesting that P-SEP appeared not to be eliminated. Furthermore, the pre-HD P-SEP levels might be predictable by the correction of hemoconcentration using even blood samples collected after starting HD with a β(2)-MG clearance < 30 mL/min.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。